IMPEDIMED LIMITED — Capital/Financing Update 2014

Dec 9, 2014

==> picture [99 x 29] intentionally omitted <==

==> picture [99 x 29] intentionally omitted <==

==> picture [99 x 30] intentionally omitted <==

10 December 2014

FOR IMMEDIATE RELEASE

The Manager Company Announcements Office ASX Limited Level 4, Exchange Centre 20 Bridge Street SYDNEY NSW 2000

Completion of non-renounceable entitlement offer

ImpediMed Limited (ABN 65 089 705 144) (ASX: IPD) ( ImpediMed ) announces the completion of its underwritten, non-renounceable pro rata entitlement offer ( Entitlement Offer ), which opened on 24 November 2014.

Under the Entitlement Offer, shareholders were invited to subscribe for 3 new Shares in ImpediMed ( New Shares ) for every 13 Shares held as at 7.00pm (AEDT) on 19 November 2014 at an issue price of $0.60 per New Share. The Entitlement Offer closed on 5 December 2014.

In accordance with the ASX Listing Rules, ImpediMed advises that it received valid applications under the Entitlement Offer for 40,707,891 new fully paid ordinary shares in ImpediMed ( New Shares ) (approximately $24.4 million).

The balance of 13,519,599 New Shares, being shares not subscribed for by shareholders in accordance with their pro rata entitlements under the Entitlement Offer, will be issued under the underwriting arrangements described in the Offer Booklet.

The Entitlement Offer will raise approximately $32.5 million before costs and expenses.

-ENDS-

For further details contact:

Steve Denaro

Company Secretary ImpediMed Limited T: +61 7 3860 3700

ImpediMed Limited ABN 65 089 705 144

Unit 1, 50 Parker Court, Pinkenba, QLD 4008 Australia • Tel +61 (7) 3860-3700 Fax +61 (7) 3260-1225 www.impedimed.com